Research could form basis for new generation of drugs
A University of Wolverhampton researcher has been awarded £4,000 to examine proteins released from body cells to aid the treatment of some serious illnesses in the future.
Dr Bernice Wright, Lecturer in Therapeutic Pharmacology at the University's Faculty of Science and Engineering, was awarded the Eric Reid Fund for Methodology from the Biochemical Society.
Her work could form the basis for the next generation of drugs to treat conditions such as heart disease.
Dr Wright's research is focused on the discovery and bio-manufacturing of cell secretomes that consist of secreted proteins and extracellular vesicles (membrane bound proteins and ribonucleic acid released from cells.
Cell secretomes have shown great promise as the basis for bio-medicines to treat heart disease, Parkinson's disease and cancer; they are also under development as biological devices for targeted clinical delivery of drugs.
They are currently major developing business models for a number of biopharmaceutical companies.
Dr Wright said: "Research is currently indicating that cell secretomes show great promise towards becoming the next generation of powerful biopharmaceutical drugs."
This work will be undertaken at the Research Institute in Healthcare Science laboratories at the University of Wolverhampton together with Dr Kesley Attridge and Professor Tracy Warr as well as national and international collaborators.
For more information please contact the Corporate Communications Team.